Reading Time: 2 minutes

FloraWorks has published their Q1 2021 CBN Market Report providing early insight into the widespread consumer adoption for CBN-infused products

Vancouver, British Columbia–(Newsfile Corp. – May 4, 2021) –

DOWNLOAD THE FULL REPORT HERE

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7206/82777_b288c9c714178828_002full.jpg

CBN Tinctures Directly To Your Door

Additionally, FloraWorks has launched a new consumer brand, Right Wellness Co. www.rightwellness.co, focused on delivering our high quality hemp derived CBN focused products to consumers nationwide.

“Consumers deserve natural plant based solutions to improve their everyday quality of life, be it sleeplessness, stress or aches and pains, and we see CBN as a viable natural alternative to existing OTC drug options.”
Alleh Lindquist, Chief Strategy Officer

Contact:
Alan Ridgeway, CEO
FloraWorks Holding Inc.
[email protected]

PR Contact :
Alleh Lindquist
[email protected]

About FloraWorks

Advancing the next generation of cannabinoid science. FloraWorks is a global leader in the supply of hemp derived CBN isolate that is legal in all 50 states. For more information on FloraWorks please visit www.flora-works.com to learn more and reach out to one of our Partnership Representatives.

Forward-Looking Statements
Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes or benefits are forward-looking statements. A number of risks and uncertainties, such as risks related to product development and commercialization efforts, ultimate clinical outcomes, and benefit of the Company’s products, market acceptance of the Company’s products, intellectual property protection, competitive product offerings, adverse changes in the public perception of cannabis, adverse changes in applicable laws and adverse changes in the application or enforcement of current laws, could cause actual events to differ from the expectations indicated in these forward-looking statements. You are cautioned not to put any undue reliance on any forward-looking statement. This press release is neither an offer to sell nor a solicitation of an offer to purchase any particular securities. Any such offer or solicitation will be made only pursuant to definitive legal agreements prepared specifically for such purpose. An investment in the Company’s securities entails significant risks and is suitable only for sophisticated investors who can afford a loss of their entire investment; no assurance can be given that investment objectives will be achieved. In considering the information contained herein, you should bear in mind that past performance is not necessarily indicative of future results; there can be no assurance that the Company will achieve comparable results or that any projected returns will be met. The Company does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/82777

Powered by WPeMatico